A path forward in the debate over health impacts of endocrine disrupting chemicals

[1]  L. Giudice,et al.  State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .

[2]  A. B. Hill,et al.  "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .

[3]  R. Zoeller,et al.  Polybrominated diphenyl ether (DE-71) interferes with thyroid hormone action independent of effects on circulating levels of thyroid hormone in male rats. , 2014, Endocrinology.

[4]  Julie E Goodman,et al.  Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. , 2014, Regulatory toxicology and pharmacology : RTP.

[5]  Anna Beronius,et al.  Facilitating the use of non‐standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting , 2014, Journal of applied toxicology : JAT.

[6]  John R. Bucher,et al.  Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.

[7]  Laura N. Vandenberg,et al.  Low-dose effects of hormones and endocrine disruptors. , 2014, Vitamins and hormones.

[8]  D. Dietrich,et al.  Endocrine disruption: fact or urban legend? , 2013, Toxicology letters.

[9]  P. Hof,et al.  Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. , 2013, Andrology.

[10]  Christopher J Borgert,et al.  Potency matters: thresholds govern endocrine activity. , 2013, Regulatory toxicology and pharmacology : RTP.

[11]  Sharon Munn,et al.  Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. , 2013, Chemosphere.

[12]  K. Coser,et al.  Expressomal approach for comprehensive analysis and visualization of ligand sensitivities of xenoestrogen responsive genes , 2013, Proceedings of the National Academy of Sciences.

[13]  G. B. Gori,et al.  Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. , 2013, Chemico-biological interactions.

[14]  J. Bucher,et al.  A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program. , 2013, Reproductive toxicology.

[15]  G. B. Gori,et al.  Open letter to the European commission: scientifically unfounded precaution drives European commission’s recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles , 2013, Archives of Toxicology.

[16]  Laura N. Vandenberg,et al.  Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors , 2013, Environmental Health.

[17]  Laura N. Vandenberg,et al.  Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. , 2013, Reproductive toxicology.

[18]  T. Woodruff,et al.  Instruments for Assessing Risk of Bias and Other Methodological Criteria of Published Animal Studies: A Systematic Review , 2013, Environmental health perspectives.

[19]  Julie E Goodman,et al.  Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? , 2012, Regulatory toxicology and pharmacology : RTP.

[20]  J. Bucher,et al.  Consortium-Based Science: The NIEHS’s Multipronged, Collaborative Approach to Assessing the Health Effects of Bisphenol A , 2012, Environmental health perspectives.

[21]  Andreas Kortenkamp,et al.  Response to A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” by Rhomberg and colleagues – letter to the editor , 2012, Critical reviews in toxicology.

[22]  T J Woodruff,et al.  Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. , 2012, Endocrinology.

[23]  P. Gluckman,et al.  Developmental origins of non-communicable disease: Implications for research and public health , 2012, Environmental Health.

[24]  G. Metz,et al.  The secret language of destiny: stress imprinting and transgenerational origins of disease , 2012, Front. Gene..

[25]  Julie E. Goodman,et al.  A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” , 2012, Critical reviews in toxicology.

[26]  Laura N. Vandenberg,et al.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.

[27]  L S McCarty,et al.  The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. , 2012, Regulatory toxicology and pharmacology : RTP.

[28]  Richard David Evans,et al.  State of the art assessment of endocrine disruptors: Final Report , 2011 .

[29]  C. Rosenfeld,et al.  Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: a review. , 2011, Seminars in reproductive medicine.

[30]  Patrice Sutton,et al.  An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.

[31]  Stuart Tobet,et al.  Cooperation of sex chromosomal genes and endocrine influences for hypothalamic sexual differentiation , 2011, Frontiers in Neuroendocrinology.

[32]  H. Mazeh,et al.  Endocrinology, Adult and Pediatric, 6th edition , 2011 .

[33]  R. Becker,et al.  Enhancing Credibility of Chemical Safety Studies: Emerging Consensus on Key Assessment Criteria , 2010, Environmental health perspectives.

[34]  P. Beck‐Peccoz,et al.  Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Müllerian derivatives: comparison with normal fetal development. , 2010, Fertility and sterility.

[35]  R. Tyl.  In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines. , 2010, Birth defects research. Part C, Embryo today : reviews.

[36]  J. Jameson,et al.  Endocrinology adult and pediatric , 2010 .

[37]  Leslie Carol Botha.  Body Burden — The Pollution in Newborns , 2010 .

[38]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[39]  I. Quesada,et al.  The pancreatic β-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes , 2009, Molecular and Cellular Endocrinology.

[40]  Ronald H. White,et al.  State-of-the-Science Workshop Report: Issues and Approaches in Low-Dose–Response Extrapolation for Environmental Health Risk Assessment , 2008, Environmental health perspectives.

[41]  J. Toppari,et al.  Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations. , 2007, International journal of andrology.

[42]  DIW Coggon,et al.  Time and chance: the stochastic nature of disease causation , 2005, The Lancet.

[43]  A. Fourrier-Réglat,et al.  Agreement of expert judgment in causality assessment of adverse drug reactions , 2005, European Journal of Clinical Pharmacology.

[44]  R. Zoeller,et al.  Timing of Thyroid Hormone Action in the Developing Brain: Clinical Observations and Experimental Findings , 2004, Journal of neuroendocrinology.

[45]  R. Newbold.  Lessons learned from perinatal exposure to diethylstilbestrol. , 2004, Toxicology and applied pharmacology.

[46]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[47]  William Owens,et al.  The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. , 2003, Environmental health perspectives.

[48]  Kristina A Thayer,et al.  Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.

[49]  J. Haseman,et al.  Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. , 2002, Environmental health perspectives.

[50]  Terri Damstra,et al.  Global assessment of the state-of-the-science of endocrine disruptors , 2002 .

[51]  E. Silbergeld,et al.  Organizational and activational effects of estrogenic endocrine disrupting chemicals. , 2002, Cadernos de saude publica.

[52]  Wout Slob,et al.  Thresholds in Toxicology and Risk Assessment , 1999 .

[53]  U. Tillmann,et al.  A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.

[54]  Rosalind,et al.  Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.

[55]  C. Vionnet.  [Environmental health]. , 1983, Krankenpflege. Soins infirmiers.

[56]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[57]  T. Paine.  Common Sense , 1995 .